The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters
NCT05399940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2022-06-01
Summary
Purpose:
To find the correlation between hemogram parameters and Delta Neutrophil Index(DNI) and Serum PSA in patients presenting with the diagnosis of acute prostatitis.
Material-Metod: Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.
Conditions
- Prostate Infection
- Prostate Disease
- Prostate Cancer
Interventions
- DIAGNOSTIC_TEST
-
Serum PSA,Delta Neutrophil Index(DNI),WBC
Urine culture, prostate volume
Sponsors & Collaborators
-
Hisar Intercontinental Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2022-05-01
- Completion
- 2022-05-20
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Open Label Trial to Assess Iressa in Prostate Cancer Patients
NCT00635856 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
NCT00955435 ·Status: UNKNOWN
-
PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802
NCT01672905 ·Status: COMPLETED
-
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154
NCT00535834 ·Status: COMPLETED
-
Response of Patients on Surveillance for Prostate Cancer to Dutasteride
NCT01525914 ·Status: COMPLETED
-
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
NCT04052048 ·Status: RECRUITING
-
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
NCT02070575 ·Status: COMPLETED
-
Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy
NCT01915316 ·Status: COMPLETED
-
Trial of Iressa in Prostate Cancer Patients
NCT00265070 ·Status: COMPLETED ·Phase: PHASE2
-
Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
NCT00898833 ·Status: TERMINATED
-
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
NCT00967954 ·Status: UNKNOWN ·Phase: NA
-
Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer
NCT02757365 ·Status: UNKNOWN ·Phase: PHASE4
-
Measurement of Circulating Tumor Cells in Prostate Cancer
NCT04101305 ·Status: UNKNOWN
-
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy
NCT04288336 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
NCT02452307 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
NCT03035500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
NCT00966095 ·Status: UNKNOWN
-
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
NCT00895310 ·Status: COMPLETED ·Phase: PHASE2
-
Prostatic Cancer Versus Androgen Deficiency
NCT02235142 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer
NCT00391690 ·Status: COMPLETED ·Phase: PHASE4
-
From PSA to Stockholm3: Study Part 1
NCT03381105 ·Status: ACTIVE_NOT_RECRUITING
-
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
NCT00664196 ·Status: SUSPENDED ·Phase: PHASE1
-
Survey of Prostate Cancer in Accra, Ghana
NCT00339534 ·Status: COMPLETED
-
A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death
NCT03619980 ·Status: COMPLETED
-
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland
NCT04530552 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2